Business

Grant of awards to Directors

Grant of awards to Directors.

articleNiox Group PlcMay 19, 20163/company/niox-group-plc/news/grant-of-awards-to-directors-5
Grant of awards to Directors

About this update from Niox Group Plc

[{"type":"text","content":"\n \nRNS Number : 7809Y Circassia Pharmaceuticals Plc 19 May 2016  \n\nFor immediate release\n \nCircassia Pharmaceuticals plc\nGrant of awards to Directors\n19 May 2016\nIn accordance with Disclosure and Transparency Rule 3.1.2 R, Circassia Pharmaceuticals plc announces the grant of options today to its Executive Directors under the rules of the Company's Performance Share Plan for 2016.\n \nThe 2016 options are granted at an exercise price of 0.08 pence to acquire ordinary shares in Circassia Pharmaceuticals plc and will normally become exercisable on the third anniversary of the Date of Grant, subject to the satisfaction of certain performance conditions. Options are awarded in two tranches of 50% each. For tranche A, options begin to vest when the Company Total Shareholder Return (TSR) ranks equal to the FTSE 250 index median TSR. At this point, 25% of options vest. This increases to 100% when the Company TSR ranks in the FTSE 250 upper quartile. For tranche B, options vest upon the achievement of strategic corporate goals in respect of the development and commercialisation of certain products and sales growth targets during the performance period.\n \nThe following table sets out details of the options that have been granted to the Executive Directors today, together with the number of options that have been previously reported and are held at 19 May 2016:\n \n\n\n\n\nName\n\n\nNew options granted on 19 May 2016\n\n\nOptions granted in earlier years and held at 19 May 2016 \n\n\nTotal number of options held at 19 May 2016\n\n\n\n\nSteven Harris\n\n\n212,946\n\n\n1,000,944\n\n\n1,213,890\n\n\n\n\nRod Hafner\n\n\n120,703\n\n\n326,278\n\n\n446,981\n\n\n\n\nJulien Cotta\n\n\n111,272\n\n\n392,412\n\n\n503,684\n\n\n\n\nTotal\n\n\n444,921\n\n\n1,719,634\n\n\n2,164,555\n\n\n\n\n \n-Ends-\n \n\n\n\n\nFor further information, please contact:\n\n\n\n\n \nCircassia Pharmaceuticals plc\nJulien Cotta, Company Secretary\n\n\n \n+44 (0) 1865 405560\n\n\n\n\n \n\nThis information is provided by RNSThe company news service from the London Stock Exchange  END  DSHGGUUWAUPQGCB\n ","length":4779,"tagName":"div"}]

More updates from Niox Group Plc